JP2025507154A5 - - Google Patents
Info
- Publication number
- JP2025507154A5 JP2025507154A5 JP2024553782A JP2024553782A JP2025507154A5 JP 2025507154 A5 JP2025507154 A5 JP 2025507154A5 JP 2024553782 A JP2024553782 A JP 2024553782A JP 2024553782 A JP2024553782 A JP 2024553782A JP 2025507154 A5 JP2025507154 A5 JP 2025507154A5
- Authority
- JP
- Japan
- Prior art keywords
- drug delivery
- ophthalmic drug
- delivery insert
- approximately
- insert according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263318823P | 2022-03-11 | 2022-03-11 | |
| US63/318,823 | 2022-03-11 | ||
| US202263320984P | 2022-03-17 | 2022-03-17 | |
| US63/320,984 | 2022-03-17 | ||
| US202263341456P | 2022-05-13 | 2022-05-13 | |
| US63/341,456 | 2022-05-13 | ||
| US202263390051P | 2022-07-18 | 2022-07-18 | |
| US63/390,051 | 2022-07-18 | ||
| PCT/US2023/064148 WO2023173093A1 (en) | 2022-03-11 | 2023-03-10 | Continuous dosing regimen for treatment of a condition of the eye |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025507154A JP2025507154A (ja) | 2025-03-13 |
| JP2025507154A5 true JP2025507154A5 (https=) | 2026-04-07 |
Family
ID=85937358
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024553782A Pending JP2025507154A (ja) | 2022-03-11 | 2023-03-10 | 眼の状態の治療を目的とした連続投薬レジメン |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250186398A1 (https=) |
| EP (1) | EP4489750A1 (https=) |
| JP (1) | JP2025507154A (https=) |
| KR (1) | KR20240156416A (https=) |
| AU (1) | AU2023230976A1 (https=) |
| CA (1) | CA3245209A1 (https=) |
| IL (1) | IL315333A (https=) |
| TW (1) | TW202400143A (https=) |
| WO (1) | WO2023173093A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3886946A1 (en) | 2019-06-05 | 2021-10-06 | Regeneron Pharmaceuticals, Inc. | Devices and methods for precision dose delivery |
| AU2021340733A1 (en) * | 2020-09-14 | 2023-05-18 | EyePoint Pharmaceuticals, Inc. | Bioerodible ocular drug delivery insert and therapeutic method |
| USD1120314S1 (en) | 2022-11-30 | 2026-03-24 | Regeneron Pharmaceuticals, Inc. | Dose delivery device |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2565683T3 (es) | 2006-09-15 | 2016-04-06 | Xcovery, Inc. | Compuestos inhibidores de quinasa |
| WO2018059556A1 (zh) | 2016-09-29 | 2018-04-05 | 贝达药业股份有限公司 | 激酶抑制剂化合物的多晶型、含其的药物组合物及其制备方法和应用 |
| EP4537830A3 (en) * | 2017-06-13 | 2025-06-11 | EyePoint Pharmaceuticals, Inc. | Bioerodible drug delivery devices |
| AU2021340733A1 (en) * | 2020-09-14 | 2023-05-18 | EyePoint Pharmaceuticals, Inc. | Bioerodible ocular drug delivery insert and therapeutic method |
-
2023
- 2023-03-10 WO PCT/US2023/064148 patent/WO2023173093A1/en not_active Ceased
- 2023-03-10 TW TW112109028A patent/TW202400143A/zh unknown
- 2023-03-10 US US18/843,571 patent/US20250186398A1/en active Pending
- 2023-03-10 AU AU2023230976A patent/AU2023230976A1/en active Pending
- 2023-03-10 JP JP2024553782A patent/JP2025507154A/ja active Pending
- 2023-03-10 CA CA3245209A patent/CA3245209A1/en active Pending
- 2023-03-10 EP EP23715702.9A patent/EP4489750A1/en active Pending
- 2023-03-10 IL IL315333A patent/IL315333A/en unknown
- 2023-03-10 KR KR1020247033492A patent/KR20240156416A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025507154A5 (https=) | ||
| JP2023541056A5 (https=) | ||
| RU2018133133A (ru) | Способ лечения атрофической возрастной макулярной дегенерации | |
| Kahook et al. | Intravitreal bevacizumab in a patient with neovascular glaucoma | |
| CA3025258C (en) | Use of sirolimus to treat exudative age-related macular degeneration with persistent edema | |
| JP2002532534A (ja) | 眼内手術における使用のための組成物セット及びキット | |
| JP2007535552A5 (https=) | ||
| JP7330510B2 (ja) | 非滲出型または萎縮型の黄斑変性にて以前に失われた視力を回復させるための医薬組成物 | |
| JP2024519629A5 (https=) | ||
| CN108261390A (zh) | 一种布林佐胺溴莫尼定滴眼液及其制备方法 | |
| CN102058581A (zh) | 一种眼科外用非甾体抗炎药 | |
| CN117159463A (zh) | 治疗青光眼的Wnt5a的调节 | |
| JP2025508127A5 (https=) | ||
| JP2016121163A (ja) | 眼内でのコルチコステロイド使用に伴う眼圧の発生を減少させる方法 | |
| Ahn et al. | Comparison of systemic atracurium, retrobulbar lidocaine, and sub‐Tenon's lidocaine injections in akinesia and mydriasis in dogs | |
| Turaka et al. | Intravitreal implant migration into anterior chamber in a post-vitrectomy eye with central retinal vein occlusion and persistent macular edema | |
| WO2020242264A1 (en) | A composition for treating eye diseases | |
| JP2022547231A5 (https=) | ||
| Duan et al. | Preliminary study of a controllable device for subtenon drug infusion in a rabbit model | |
| Loane et al. | Glaucoma secondary to epithelial downgrowth and 5-fluorouracil | |
| Jourieh | Safety and Efficacy of Suprachorodial Injection of Triamcinolone Acetonide: Review of a Novel Treatment. | |
| CN116515827A (zh) | 用于治疗年龄相关性黄斑变性的活性成分、药物组合物和应用 | |
| JP2024531861A (ja) | Ｓｇｌｔ－２阻害剤を含む糖尿病性眼疾患の予防または治療用薬学的組成物 | |
| Ashton | Huge therapeutic advances: Bigger drug delivery opportunities | |
| RU2675691C1 (ru) | Способ длительной перфузии субтенонового пространства лекарственными средствами |